David E. Kandzari, MD

Country USA
Specialty Interventional Cardiologist
  1. Renal Denervation: Latest Clinical Evidence and Update
  2. Results and Update from the SPYRAL Hypertension Program(OFF-MED and ON-MED Trials)
  3. Data and Application of Ultra-Thin Strut DES: Is It Also Working for Complex Lesions?
  4. Ultrathin Strut Bioresorbable Polymer DES : New Benchmark in the Field of DES
  5. CHIP/Complex PCI in 2018: Practical, Operational, and Logistical Aspects
  6. Future DES Platforms: New Drugs, Polymers, and Metals
  7. Updated RCT for Left Main: EXCEL & NOBLE - Long-Term, Subgroup, and New Data
  8. Bioabsorbable Polymer DES in High Risk Patients
  9. From DES to BVS: Which Techniques and Which Stents?
  10. Mechanisms and Clinical Evidence for Expanded Indications (HF, DM, Arrythmia, or Sleep Apnea Improvement)
  11. Renal Denervation: Key Results from Symplicity HTN3
  12. EXCEL Trial Update
  13. Symplicity HTN 3: Where Are We Going to?
  14. Application of Renal Denervation to Treatment of Chronic Heart Failure
  15. Catheter-based Renal Denervation for Hypertension and Other Area of Future Research
  16. What's the Final Goal of Transcatheter Renal Denervation?
  17. SES Revisited: The ¡°Unexpected¡± Results and Clinical Implications from BASKET-PROVE, SORT-OUT IV, and ISAR-TEST 4
  18. Major Trials for Catheter-Based Coronary Interventions (SPIRIT IV, COMPARE, ZEST, ISAR-TEST4, ISAR-DESIRE 2, NORDIC-BALTIC BIFURCATION STUDY III, and PEPCAD III)
  19. Prasugrel: TRITON - Evolution Begins Here !!
  20. Safety Issue in DES Era
  21. What Is the Optimal Duration of DAPT Following DES Treatment?
  22. Outcomes of Zotarolimus Eluting Stent in Diabetics: Results from the E-FIVE Registry
  23. Critical Review of Interventional Options for the SFA: Current Devices and Future Directions
  24. Rationale for Chronic Total Occlusion Revsacularization
  25. What Is the Optimal Duration of Dual Antiplatelet Therapy Following DES Treatment?
  26. Overview of the Sirolimus Eluting Stent Program: A Spectrum of Safety and Efficacy Among Differing DES
  27. Safety of DES in Diabetics
  28. Comparative Trials of DES Safety and Efficacy Role of DES in Chronic Total Occlusions: Results of The ACROSS Trial Evaluating SES in Chronic Total Occlusions
  29. Future Technologies from Cordis
  30. Chronic Total Occlusions
  31. Chronic Total Occlusions: Evidence Based Rationale for Recanalization and DES
  32. ENDEAVOR-III: 1 Year Results